Survival, response rates, and post-transplant outcomes in patients with Acute Myeloid Leukemia aged 60-75 treated with high intensity chemotherapy vs. lower intensity targeted therapy

Overview of attention for article published in Frontiers in oncology, October 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 29,987 followers.

RT @KSahasra_MD: https://t.co/djre0YZL76 Our recent retrospective comparing intensive vs. targeted AML therapies in patients aged 60-75. Tr…

04 Nov 2022

Reply Repost Favourite

RT @KSahasra_MD: https://t.co/djre0YZL76 Our recent retrospective comparing intensive vs. targeted AML therapies in patients aged 60-75. Tr…

04 Nov 2022

Reply Repost Favourite

New article: Survival, response rates, and post-transplant outcomes in patients with Acute Myeloid Leukemia aged 60-75 treated with high intensity chemotherapy vs. lower intensity targeted therapy https://t.co/ORXDcu3BZ9 #AML #leusm #hematology https://t.c

20 Oct 2022

Reply Repost Favourite

Survival, response rates, and post-transplant outcomes in patients with Acute Myeloid Leukemia aged 60-75 treated with high intensity chemotherapy vs. lower intensity targeted therapy: The United States Food and Drug… #oncology https://t.co/DzHS82CozE http

04 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.